|
Neomycin and Polymyxin B Sulfates, Bacitracin, and Hydrocortisone Acetate Ointment
» Neomycin and Polymyxin B Sulfates, Bacitracin, and Hydrocortisone Acetate Ointment contains the equivalent of not less than 90.0 percent and not more than 130.0 percent of the labeled amounts of neomycin, polymyxin B, and bacitracin, and not less than 90.0 percent and not more than 110.0 percent of the labeled amount of hydrocortisone acetate in a suitable ointment base.
Packaging and storage
Preserve in collapsible tubes or in well-closed containers.
USP Reference standards
USP Bacitracin Zinc RS
USP Neomycin Sulfate RS
USP Polymyxin B Sulfate RS
Identification
A:
It meets the requirements under Thin-Layer Chromatographic Identification Test
B:
The retention time of the major peak for hydrocortisone acetate in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay for hydrocortisone acetate.
Minimum fill
Water, Method I
Assay for neomycin and Assay for polymyxin B
Proceed with Ointment as directed in the Assay for neomycin and in the Assay for polymyxin B under Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment.
Assay for bacitracin
Proceed with Ointment as directed in the Assay under Bacitracin Ointment.
Assay for hydrocortisone acetate
Proceed with Ointment as directed in the Assay under Hydrocortisone Acetate Lotion.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 4021
Pharmacopeial Forum: Volume No. 30(2) Page 519
|